AstraZeneca AB Liquid Production Sweden is a division of AstraZeneca, a global biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. This facility in Södertälje specializes in the production of liquid formulations, contributing to the company's broader portfolio of pharmaceutical products. AstraZeneca is known for its work in various therapeutic areas, including oncology, cardiovascular, renal, and respiratory diseases.
The Södertälje site plays a significant role in AstraZeneca's manufacturing operations, utilizing advanced technologies and processes to ensure the quality and efficiency of its production. The facility is equipped to handle the complexities of liquid drug formulation, which is essential for delivering effective treatments to patients. AstraZeneca's commitment to innovation and quality in pharmaceutical manufacturing is reflected in its operations at this location, which adheres to stringent regulatory standards.
In addition to its production capabilities, AstraZeneca AB Liquid Production Sweden is part of the company's global network, which facilitates collaboration and knowledge sharing across its various sites. This integration supports AstraZeneca's mission to improve patient outcomes through the development of new therapies and the efficient production of existing medications.